CDC42EP4
Cdc42 effector protein 4
Also known as: BORG4, BORG4_HUMAN, CEP4, KAIA1777, MGC17125, MGC3740
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H3Q1
- Gene
- CDC42EP4
- Ensembl
- ENSG00000179604
- Chromosome
- 17
- Canonical length
- 356 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Actin filaments,Microtubules
OverviewNCBI Gene
The product of this gene is a member of the CDC42-binding protein family. Members of this family interact with Rho family GTPases and regulate the organization of the actin cytoskeleton. This protein has been shown to bind both CDC42 and TC10 GTPases in a GTP-dependent manner. When overexpressed in fibroblasts, this protein was able to induce pseudopodia formation, which suggested a role in inducing actin filament assembly and cell shape control. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
356 residues, UniProt reviewed canonical sequence.
>Q9H3Q1|CDC42EP4
1 MPILKQLVSS SVHSKRRSRA DLTAEMISAP LGDFRHTMHV GRAGDAFGDT SFLNSKAGEP
61 DGESLDEQPS SSSSKRSLLS RKFRGSKRSQ SVTRGEREQR DMLGSLRDSA LFVKNAMSLP
121 QLNEKEAAEK GTSKLPKSLS SSPVKKANDG EGGDEEAGTE EAVPRRNGAA GPHSPDPLLD
181 EQAFGDLTDL PVVPKATYGL KHAESIMSFH IDLGPSMLGD VLSIMDKEEW DPEEGEGGYH
241 GDEGAAGTIT QAPPYAVAAP PLARQEGKAG PDLPSLPSHA LEDEGWAAAA PSPGSARSMG
301 SHTTRDSSSL SSCTSGILEE RSPAFRGPDR ARAAVSRQPD KEFSFMDEEE EDEIRVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDC42EP4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.71
- Highest tissue expression
- 92 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 92 nTPM
- retina: 91 nTPM
- cerebellum: 77 nTPM
- breast: 75 nTPM
- basal ganglia: 74 nTPM
- pancreas: 73 nTPM
Single-cell type
- müller glia: 790 nCPM
- retinal horizontal cells: 487 nCPM
- bergmann glia: 304 nCPM
- respiratory basal cells: 264 nCPM
- pituicytes/fscs: 263 nCPM
- esophageal basal cells: 212 nCPM
Immune cell
- non-classical monocyte: 20 nTPM
- intermediate monocyte: 8.5 nTPM
- eosinophil: 5.9 nTPM
- neutrophil: 5.4 nTPM
- myeloid DC: 4.3 nTPM
- basophil: 3.4 nTPM
Brain region
- medulla oblongata: 229 nTPM
- white matter: 154 nTPM
- thalamus: 150 nTPM
- midbrain: 149 nTPM
- spinal cord: 147 nTPM
- hypothalamus: 146 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0.21
- gnomAD missense Z
- 0.33
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to type II interferon
- positive regulation of actin filament polymerization
- positive regulation of pseudopodium assembly
- regulation of cell shape
- Rho protein signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDC42EP4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDC42EP4 as an antibody target. Whether an autoantibody or antibody against CDC42EP4 could matter depends on whether native CDC42EP4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDC42EP4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDC42EP4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...